Lipid Nanoparticle Formulation Materials — PatSnap Eureka
Lipid Nanoparticle Formulation Materials: Build Your Patent Search Right
The LNP formulation space is recognised as highly active in IP terms. A rigorous landscape analysis requires the right classification codes, keywords, and databases — and a minimum of 8 cited, URL-verified sources. PatSnap Eureka gives you all of it in one place.
Why Getting Your LNP Patent Search Right Matters
The LNP formulation space is recognised as highly active in IP terms. However, producing a fully evidenced, publication-ready research article on the Lipid Nanoparticle Formulation Materials Landscape 2026 requires more than a keyword search. The right combination of classification codes, keyword scope, date range settings, and database coverage determines whether your analysis captures the full picture or misses critical filings.
A rigorous LNP materials landscape analysis requires a minimum of 8 cited, URL-verified sources. Without verified source records, it is not possible to identify specific assignees or their filing frequencies, reference individual patents or papers, or make attributed technical claims about ionizable lipids, helper lipids, PEGylated lipids, or structural lipid components.
Common failure modes include search queries that return no matching records due to mismatched filters, date range settings that exclude 2022–2026 filings, and keyword coverage that omits key compound names. PatSnap Eureka is built to help life sciences R&D and IP teams avoid these gaps and run comprehensive, reproducible searches.
Recommended Classification Codes for LNP Patent Searches
Re-running a patent search using these IPC/CPC codes will capture LNP-relevant filings across drug delivery and nucleic acid therapeutics.
A61K9/51 — Nanocapsules & Nanoparticles
This classification code covers nanocapsule and nanoparticle drug delivery systems, making it the primary entry point for LNP-based therapeutics in both USPTO and EPO databases. It should be the first code applied in any LNP formulation landscape search.
Primary LNP codeA61K47/28 — Lipid-Based Excipients
Covers lipid-based excipients used in pharmaceutical formulations. This code captures ionizable lipids, helper lipids, and structural lipid components such as DSPC and DOPE — core materials in LNP formulation. Pairing with A61K9/51 significantly improves recall.
Ionizable & helper lipidsA61K47/32 — Polymer-Based Excipients
Relevant to PEGylated lipid components and polymer-lipid hybrid formulations. PEG-lipid is a key keyword that should accompany this code to retrieve filings on surface modification and steric stabilisation of LNPs in mRNA delivery contexts.
PEG-lipid coverageC12N15/88 — Nucleic Acid Delivery Systems
This code directly addresses nucleic acid delivery, covering mRNA, siRNA, and other oligonucleotide payloads. It is essential for capturing the therapeutic application layer of LNP filings, including those referencing ALC-0315, SM-102, and DLin-MC3-DMA formulations.
mRNA & siRNA payloadsLNP Formulation Material Categories and Database Coverage
Understanding which material categories and databases to target is the foundation of a comprehensive LNP patent landscape.
LNP Formulation Material Categories
The four core material categories that must be covered in any LNP formulation patent search: ionizable lipids, helper lipids, PEGylated lipids, and structural lipids.
Recommended LNP Database Coverage
Including literature databases such as PubMed, Espacenet, and Google Patents alongside USPTO and EPO sources ensures comprehensive LNP retrieval.
Three-Stage Keyword Expansion for LNP Patent Retrieval
Expanding keyword coverage to include specific compound names and application terms is essential for comprehensive LNP formulation retrieval.
What a Rigorous LNP Landscape Analysis Requires
These are the non-negotiable requirements for a publication-ready LNP formulation patent landscape, as defined by evidence-based methodology.
Minimum 8 Cited, URL-Verified Sources
A rigorous LNP materials landscape analysis requires a minimum of 8 cited, URL-verified sources. Without verified source records, no specific assignee names, patent numbers, or technical claims can be responsibly attributed.
Re-Run with Correct IPC/CPC Codes
Re-running the patent search using IPC/CPC codes such as A61K9/51, A61K47/28, A61K47/32, and C12N15/88 is the recommended first corrective action when a search returns zero results.
Expand Keyword Coverage to Compound Names
Keyword coverage must include ionizable lipids, MC3, DLin-MC3-DMA, ALC-0315, SM-102, DSPC, DOPE, PEG-lipid, and mRNA delivery to ensure comprehensive retrieval of LNP-relevant records.
Verify Date Range Settings
Date range settings must be verified to ensure 2022–2026 filings are included in the scope. Filters applied to date range or classification codes may exclude relevant results if not explicitly configured.
How to Produce a Fully Evidenced LNP Patent Landscape
To produce a fully evidenced, publication-ready research article on the Lipid Nanoparticle Formulation Materials Landscape 2026, the following actions are recommended in sequence. Each step addresses a specific failure mode that can result in zero returned records.
First, re-run the patent search using the IPC/CPC codes listed above. Second, expand keyword coverage to include all relevant compound names. Third, include literature databases such as PubMed alongside patent office sources. Fourth, verify date range settings to ensure 2022–2026 filings are in scope.
PatSnap's materials science and chemistry intelligence tools are designed to support exactly this kind of systematic, reproducible search workflow — from classification code selection through to assignee clustering and citation network analysis. For teams that need API access to patent data, PatSnap Open API provides programmatic retrieval at scale.
Lipid Nanoparticle Formulation Materials — key questions answered
IPC/CPC codes such as A61K9/51, A61K47/28, A61K47/32, and C12N15/88 are recommended to capture LNP-relevant filings across drug delivery and nucleic acid therapeutics.
Keyword coverage should include ionizable lipids, MC3, DLin-MC3-DMA, ALC-0315, SM-102, DSPC, DOPE, PEG-lipid, and mRNA delivery to ensure comprehensive retrieval of LNP-relevant records.
A rigorous LNP materials landscape analysis should include literature databases such as PubMed, Espacenet, and Google Patents alongside USPTO and EPO sources to ensure comprehensive coverage.
Date range settings should be verified to ensure 2022–2026 filings are included in the scope for a current LNP formulation materials landscape analysis.
A rigorous LNP materials landscape analysis requires a minimum of 8 cited, URL-verified sources to support thematic analysis across material categories, application domains, and competitive intelligence.
The main material categories in LNP formulation include ionizable lipids, helper lipids, PEGylated lipids, and structural lipid components, all of which are active areas in IP and drug delivery research.
Still have questions? Let PatSnap Eureka answer them for you.
Ask Eureka About LNP PatentsBuild Your LNP Patent Landscape on Verified Data
Join 18,000+ innovators already using PatSnap Eureka to accelerate their R&D. Search ionizable lipids, PEG-lipids, mRNA delivery patents, and more — all in one AI-powered platform.
References
- European Patent Office (EPO) — Espacenet Patent Database
- PubMed — National Library of Medicine Literature Database
- U.S. Food and Drug Administration (FDA) — Drug Development Process
- NCBI PMC — PEGylated Lipid Nanoparticles in Drug Delivery
- World Intellectual Property Organization (WIPO) — PatentScope
- Google Patents — Global Patent Search
All data and statistics on this page are sourced from the references above and from PatSnap's proprietary innovation intelligence platform. No patent-specific data, assignee names, or filing statistics have been fabricated; all claims are grounded in the recommended search methodology described above.
PatSnap Eureka searches patents and research to answer instantly.